MSC
Showing 1 - 25 of >10,000
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Osteo Arthritis Knee Trial ("Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product, Resuspended
Not yet recruiting
- Osteo Arthritis Knee
- "Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
- Resuspended Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
- (no location specified)
Feb 20, 2023
Ischemic Stroke Trial (MSC)
Not yet recruiting
- Ischemic Stroke
- MSC
- (no location specified)
Jan 24, 2023
UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Enrolling by invitation
- Retinitis Pigmentosa
- Conditioned Medium (CM)
- Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
Mar 14, 2023
Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)
Not yet recruiting
- Retinitis Pigmentosa
- 1.5 x 10^6 UC-MSC + CM
- 5 x 10^6 UC-MSC + CM
- (no location specified)
Jun 11, 2023
Liver Failure, Acute on Chronic Trial in Guangzhou (MSC-EV)
Not yet recruiting
- Liver Failure, Acute on Chronic
- MSC-EV
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
May 30, 2023
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
Acute-On-Chronic Liver Failure, Acute Liver Failure Trial in Guangzhou (MSC-EVs)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- Acute Liver Failure
- MSC-EVs
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
Jul 14, 2023
Autism Spectrum Disorder Trial in Durham (hCT-MSC infusion)
Completed
- Autism Spectrum Disorder
- hCT-MSC infusion
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Self-compassion, Mindfulness, Mental Health Trial in Salamanca (Mindful Self-Compassion (MSC) training, Mindfulness Based Stress
Recruiting
- Self-compassion
- +5 more
- Mindful Self-Compassion (MSC) training
- Mindfulness Based Stress Reduction (MBSR) training
-
Salamanca, Salamanca (Castilla Y León), SpainUniversidad Pontificia de Salamanca
Jan 19, 2023
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)
Active, not recruiting
- Multiple Sclerosis
- Intrathecal MSC-NP injection
- Intrathecal saline injection
-
New York, New YorkTisch MS Research Center of New York
Oct 25, 2022
Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)
Not yet recruiting
- Allogeneic Disease
- +2 more
- WJ-MSC infusion
- (no location specified)
May 4, 2023
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)
Not yet recruiting
- Dry Eye Disease
- Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- MSC-IFNα
- +3 more
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023
Preterm Babies Trial in Erzurum (Breast milk-scented PIOMI, Breast milk-tasting PIOMI)
Not yet recruiting
- Preterm Babies
- Breast milk-scented PIOMI
- Breast milk-tasting PIOMI
-
Erzurum, TurkeyAtaturk University
Sep 14, 2023
Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))
Completed
- Multiple Sclerosis, Chronic Progressive
- NurOwn (MSC-NTF cells)
-
Los Angeles, California
- +3 more
Oct 20, 2022
Kidney Transplant Trial in Rochester (Low dose adipose tissue derived mesenchymal stromal cells (A-MSC), High dose adipose
Recruiting
- Kidney Transplant
- Low dose adipose tissue derived mesenchymal stromal cells (A-MSC)
- High dose adipose tissue derived mesenchymal stromal cells (A-MSC)
-
Rochester, MinnesotaMayo Clinic
Jul 8, 2022
Chronic Kidney Diseases Trial in Wuhan (UC-MSC, Saline solution)
Recruiting
- Chronic Kidney Diseases
- UC-MSC
- Saline solution
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Aug 21, 2022
Facet-Mediated Low Back Pain Trial in Jacksonville (BM-MSC injection, DSMO Injection)
Recruiting
- Facet-Mediated Low Back Pain
- BM-MSC injection
- DSMO Injection
-
Jacksonville, FloridaMayo Clinic in Florida
Aug 18, 2023
Autism, Autism Spectrum Disorder Trial in Durham (Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion)
Active, not recruiting
- Autism
- Autism Spectrum Disorder
- Cord Tissue Mesenchymal Stromal Cells
- Placebo Infusion
-
Durham, North CarolinaDuke University Medical Center
Oct 26, 2022
Depression, Anxiety Trial in Xiangtan (MSC intervention)
Completed
- Depression, Anxiety
- MSC intervention
-
Xiangtan, Hunan, ChinaXiangtan Central Hospital
Dec 15, 2022
Autism Spectrum Disorder, Autism Trial in Durham (hCT-MSC)
Recruiting
- Autism Spectrum Disorder
- Autism
- hCT-MSC
-
Durham, North CarolinaDuke University Medical Center
Apr 19, 2022
Chronic Lung Allograft Dysfunction (CLAD) Trial in Australia (Bone-marrow derived MSCs, Placebo)
Active, not recruiting
- Chronic Lung Allograft Dysfunction (CLAD)
- Bone-marrow derived MSCs
- Placebo
-
Sydney, New South Wales, Australia
- +4 more
Aug 22, 2022
ARDS, Human Trial (intravenous delivery of allogeneic bone marrow-derived MSCs)
Not yet recruiting
- ARDS, Human
- intravenous delivery of allogeneic bone marrow-derived MSCs
- (no location specified)
Aug 5, 2022